Charehbili, A.; Fontein, D.B.Y.; Kroep, J.R.; Liefers, G.-J.; Nortier, J.W.R.; Velde, C.J.H.v.d.
Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? J. Clin. Med. 2013, 2, 188-200.
https://doi.org/10.3390/jcm2040188
AMA Style
Charehbili A, Fontein DBY, Kroep JR, Liefers G-J, Nortier JWR, Velde CJHvd.
Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Journal of Clinical Medicine. 2013; 2(4):188-200.
https://doi.org/10.3390/jcm2040188
Chicago/Turabian Style
Charehbili, Ayoub, Duveken B. Y. Fontein, Judith R. Kroep, Gerrit-Jan Liefers, Johannes W. R. Nortier, and Cornelis J. H. van de Velde.
2013. "Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?" Journal of Clinical Medicine 2, no. 4: 188-200.
https://doi.org/10.3390/jcm2040188
APA Style
Charehbili, A., Fontein, D. B. Y., Kroep, J. R., Liefers, G.-J., Nortier, J. W. R., & Velde, C. J. H. v. d.
(2013). Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Journal of Clinical Medicine, 2(4), 188-200.
https://doi.org/10.3390/jcm2040188